Table 5.
Linear regression for eGFR changes after surgery.
| Variables | Univariate Model | Multivariable Model b | ||
|---|---|---|---|---|
| β ± SE a (95% CI) | p | β ± SE a (95% CI) | p | |
| EA vs. RNU | 17.9 ± 4.13 | <0.001 | 12.9 ± 4.92 | 0.011 |
| Age (per 5 years) | −1.12 ± 0.68 | 0.105 | ||
| Male vs. Female | −16.1 ± 4.33 | <0.001 | −12.89 ± 4.02 | 0.002 |
| High grade vs. Low grade | −4.10 ± 4.71 | 0.387 | ||
| cT1 vs. cTa | −8.16 ± 5.32 | 0.130 | ||
| Previous/Conc. UC (Yes/No) | −3.39 ± 5.44 | 0.535 | ||
| Tumor Size (≥3/<3 cm) | 8.96 ± 4.70 | 0.061 | ||
| Tumor location (RP c/w Ureter/Ureter alone) | −6.11 ± 4.67 | 0.196 | ||
| Hydronephrosis (Yes vs. No) | 4.53 ± 4.81 | 0.350 | ||
| Adjuvant IVCT (Yes vs. No) | 1.00 ± 10.09 | 0.922 | ||
| CIS (Yes vs. No) | −8.82 ± 6.96 | 0.210 | ||
| Multifocal (Yes vs. No) | −19.96 ± 4.69 | <0.001 | −6.34 ± 5.79 | 0.278 |
eGFR, estimated glomerular filtration rate; EA, endoscopic ablation; RNU, radical nephroureterectomy; Conc., concomitant; UC, urothelial carcinoma; c/w, with/without; IVCT, intravesical chemotherapy; CIS, carcinoma in situ. a Weighted by inverse probability of treatment; b Multivariable linear regression analysis of variables (Group variable and p < 0.05 in univariate linear regression).